Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Paroxetine Versus Bupropion for Suicide Ideators or Attempters With Major Depressive Disorder.

Trial Profile

Paroxetine Versus Bupropion for Suicide Ideators or Attempters With Major Depressive Disorder.

Discontinued
Phase of Trial: Phase IV

Latest Information Update: 01 Nov 2018

At a glance

  • Drugs Bupropion (Primary) ; Paroxetine (Primary)
  • Indications Major depressive disorder; Suicidal ideation
  • Focus Therapeutic Use
  • Most Recent Events

    • 23 Jan 2013 Status changed from recruiting to discontinued as reported by ClinicalTrials.gov.
    • 08 Feb 2012 Planned number of patients changed from 100 to 125.
    • 03 Feb 2012 Planned end date changed from 1 Jan 2010 to 1 Jan 2013 as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top